The different autophagy degradation pathways and neurodegeneration
Copyright © 2022 Elsevier Inc. All rights reserved..
The term autophagy encompasses different pathways that route cytoplasmic material to lysosomes for degradation and includes macroautophagy, chaperone-mediated autophagy, and microautophagy. Since these pathways are crucial for degradation of aggregate-prone proteins and dysfunctional organelles such as mitochondria, they help to maintain cellular homeostasis. As post-mitotic neurons cannot dilute unwanted protein and organelle accumulation by cell division, the nervous system is particularly dependent on autophagic pathways. This dependence may be a vulnerability as people age and these processes become less effective in the brain. Here, we will review how the different autophagic pathways may protect against neurodegeneration, giving examples of both polygenic and monogenic diseases. We have considered how autophagy may have roles in normal CNS functions and the relationships between these degradative pathways and different types of programmed cell death. Finally, we will provide an overview of recently described strategies for upregulating autophagic pathways for therapeutic purposes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:110 |
---|---|
Enthalten in: |
Neuron - 110(2022), 6 vom: 16. März, Seite 935-966 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fleming, Angeleen [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 05.04.2022 Date Revised 17.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.neuron.2022.01.017 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336667116 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336667116 | ||
003 | DE-627 | ||
005 | 20231225232649.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.neuron.2022.01.017 |2 doi | |
028 | 5 | 2 | |a pubmed24n1122.xml |
035 | |a (DE-627)NLM336667116 | ||
035 | |a (NLM)35134347 | ||
035 | |a (PII)S0896-6273(22)00056-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fleming, Angeleen |e verfasserin |4 aut | |
245 | 1 | 4 | |a The different autophagy degradation pathways and neurodegeneration |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.04.2022 | ||
500 | |a Date Revised 17.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
520 | |a The term autophagy encompasses different pathways that route cytoplasmic material to lysosomes for degradation and includes macroautophagy, chaperone-mediated autophagy, and microautophagy. Since these pathways are crucial for degradation of aggregate-prone proteins and dysfunctional organelles such as mitochondria, they help to maintain cellular homeostasis. As post-mitotic neurons cannot dilute unwanted protein and organelle accumulation by cell division, the nervous system is particularly dependent on autophagic pathways. This dependence may be a vulnerability as people age and these processes become less effective in the brain. Here, we will review how the different autophagic pathways may protect against neurodegeneration, giving examples of both polygenic and monogenic diseases. We have considered how autophagy may have roles in normal CNS functions and the relationships between these degradative pathways and different types of programmed cell death. Finally, we will provide an overview of recently described strategies for upregulating autophagic pathways for therapeutic purposes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
700 | 1 | |a Bourdenx, Mathieu |e verfasserin |4 aut | |
700 | 1 | |a Fujimaki, Motoki |e verfasserin |4 aut | |
700 | 1 | |a Karabiyik, Cansu |e verfasserin |4 aut | |
700 | 1 | |a Krause, Gregory J |e verfasserin |4 aut | |
700 | 1 | |a Lopez, Ana |e verfasserin |4 aut | |
700 | 1 | |a Martín-Segura, Adrián |e verfasserin |4 aut | |
700 | 1 | |a Puri, Claudia |e verfasserin |4 aut | |
700 | 1 | |a Scrivo, Aurora |e verfasserin |4 aut | |
700 | 1 | |a Skidmore, John |e verfasserin |4 aut | |
700 | 1 | |a Son, Sung Min |e verfasserin |4 aut | |
700 | 1 | |a Stamatakou, Eleanna |e verfasserin |4 aut | |
700 | 1 | |a Wrobel, Lidia |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Ye |e verfasserin |4 aut | |
700 | 1 | |a Cuervo, Ana Maria |e verfasserin |4 aut | |
700 | 1 | |a Rubinsztein, David C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neuron |d 1994 |g 110(2022), 6 vom: 16. März, Seite 935-966 |w (DE-627)NLM012616826 |x 1097-4199 |7 nnns |
773 | 1 | 8 | |g volume:110 |g year:2022 |g number:6 |g day:16 |g month:03 |g pages:935-966 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.neuron.2022.01.017 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 110 |j 2022 |e 6 |b 16 |c 03 |h 935-966 |